A vitamin A discovery is changing what scientists know about vision
Johns Hopkins researchers have discovered how a vitamin A-derived molecule interacts with thyroid hormones to form sharp central vision in the human retina. This breakthrough could lead to new treatments for degenerative eye diseases like macular degeneration.
Why it matters
Understanding the biological development of the foveola provides a foundation for future regenerative medicine and vision restoration therapies.
Scientists at Johns Hopkins University have uncovered how humans develop sharp central vision before birth, identifying a carefully timed interaction between a vitamin A derived molecule and thyroid hormones in the retina. The discovery challenges a decades old explanation for how key light sensing cells form and could guide future treatments for macular degeneration, glaucoma, and other diseases that damage vision.
The report is a straightforward summary of scientific research published in a peer-reviewed journal.
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in